Made for you. Sent to you.Licensed 503A pharmacyPrescribed only if it fits youExpedited shipping, cold-packed when needed
MicrodoseWhat it does.
Same medicine, lower doseYou use a smaller weekly amount of compounded semaglutide or tirzepatide.
Gentler rampLower doses may mean fewer or milder stomach side effects for some people.
Provider-ledYour provider picks the dose and adjusts it based on how you feel.
Lifestyle firstIt works best alongside protein, strength training, sleep and hydration.
Made to fit your day.
Weekly injection. At home. On your schedule.
Online review, 24 hours or less
Did you know503A
Compounded medicines are prepared for an individual patient by a licensed pharmacy. They are not FDA-approved and are not reviewed by the FDA for safety or effectiveness.
Source: FDA
Did you know2 days
Adults should do muscle-strengthening activity that works all major muscle groups at least 2 days a week.
Source: CDC
Compounded by a licensed 503A pharmacyMetabolic health · Compounded
Microdose GLP-1: a lower-dose plan, guided by a provider
Microdosing means a lower weekly dose of a compounded GLP-1 for metabolic health support, chosen with a licensed provider. Compounded by a licensed 503A pharmacy, not FDA-approved.
Weekly injection
Lower dose
Labs optional
1. Choose your supplyNo auto-subscribe. Pick 30 or 90 days, skip a month when you need to.
Already on a GLP-1? To continue at your current dose, share a prescription from the last 30 days. Otherwise you start at the lowest dose, and your provider can talk with you about adjusting it.
2. How you get care
Online review, 24 hours or lessShips discreetly to your door
Prescription required. If a provider decides treatment is not appropriate, you are not charged for treatment.
Product images are mockups for demonstration only. Your medication is prepared and dispensed by a licensed U.S. pharmacy, and its actual form, packaging and appearance may differ.
Blood sugar that keeps creeping upSnoring or poor sleepTired of starting over every MondayMetabolism that feels stuck
Feel like you again.
Metabolic health care that works with your body, not against it.
What is microdosing a GLP-1?
Microdosing is a plan that uses lower, steady doses of a compounded GLP-1 medicine instead of stepping up to higher doses. KIN Meds offers two options: Microdose Personalized GLP-1 (compounded semaglutide) and Microdose Personalized GLP-1/GIP (compounded tirzepatide with added B vitamins), both as a weekly injection.
Microdosing is not an FDA-approved dosing plan, and there is limited research on it. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. A licensed provider decides whether a lower-dose plan is appropriate for you.
Infographic
How a lower-dose plan works
1Same medicine, lower doseYou use a smaller weekly amount of compounded semaglutide or tirzepatide.
→
2Gentler rampLower doses may mean fewer or milder stomach side effects for some people.
→
3Provider-ledYour provider picks the dose and adjusts it based on how you feel.
→
4Lifestyle firstIt works best alongside protein, strength training, sleep and hydration.
Video coming soon
Microdose in 60 seconds
A quick, plain-English explainer from the KIN Meds care team: what it is, who it may fit, and what to expect.
How your care works
What to expect
Step 1 of 4
Day 1
Complete your online intake. A licensed provider reviews it in 24 hours or less.
Step 2 of 4
Delivery
Ships from licensed U.S. partner pharmacies with expedited shipping, cold-packed when needed.
Step 3 of 4
First month
You start at a low weekly dose and track how you feel.
Step 4 of 4
Check-ins
Your provider reviews your progress and side effects and decides on any change.
503ACompounded medicines are prepared for an individual patient by a licensed pharmacy. They are not FDA-approved and are not reviewed by the FDA for safety or effectiveness.
2 daysAdults should do muscle-strengthening activity that works all major muscle groups at least 2 days a week.
Adults who meet criteria for GLP-1 treatment and want a lower-dose approach
People who had trouble with side effects at higher doses
People working with a provider on a longer-term plan
People comfortable with a small weekly injection at home
Probably not for you if
anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
people who are pregnant, trying to get pregnant, or breastfeeding
type 1 diabetes, or anyone under 18
a current or past eating disorder, or bariatric surgery in the last 6 months
a history of pancreatitis without your provider's review first
Did you know
The numbers.
503A
Compounded medicines are prepared for an individual patient by a licensed pharmacy. They are not FDA-approved and are not reviewed by the FDA for safety or effectiveness.
Source: FDA
2 days
Adults should do muscle-strengthening activity that works all major muscle groups at least 2 days a week.
Source: CDC
1 in 3
U.S. adults have prediabetes, and more than 8 in 10 of them do not know they have it.
Source: CDC
Your care team
Real providers. Real answers.
Every intake is reviewed by a licensed provider, not a bot. Physicians, nurse practitioners and physician assistants who know hormones, weight and healthy aging, and who treat you like a person.
Licensed in the state where you live
Review in 24 hours or less
Message your care team any time
Video visits for TRT and hormone care ages 35 to 39
Images show models.
Nurse practitioner
Physician
Physician assistant
Physician
Safety information
This is a compounded medication, compounded by a licensed 503A pharmacy for you as an individual patient. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. A licensed provider decides whether treatment is appropriate. Prescription required.
Full safety information
Important: Class warning for GLP-1 medicines: risk of thyroid C-cell tumors. In rodent studies, medicines in this class caused thyroid C-cell tumors. It is not known if they cause these tumors, including medullary thyroid carcinoma (MTC), in people. Do not use if you or any family member has ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider right away about a lump or swelling in your neck, trouble swallowing, hoarseness or shortness of breath.
A lower dose does not remove the risks of GLP-1 medicines. The most common side effects are nausea, vomiting, diarrhea, constipation, belly pain and lower appetite. They are most likely when you start or step up a dose and often ease with time. Serious but less common risks include pancreatitis, gallbladder problems, low blood sugar (especially with insulin or a sulfonylurea), kidney problems from dehydration, serious allergic reactions, and changes in mood. Get emergency care for severe belly pain that will not go away, signs of an allergic reaction, or thoughts of self-harm.
Not for use during pregnancy. Stop at least 2 months before a planned pregnancy and tell your provider if you are breastfeeding. Tell the care team if you have surgery planned, since these medicines can affect anesthesia and how your stomach empties.
Compounded vials require careful measuring. Follow your provider and pharmacy instructions exactly.
Microdosing a GLP-1 means using a lower, steady weekly dose instead of stepping up to higher doses over time. At KIN Meds, a licensed provider chooses the dose of compounded semaglutide or compounded tirzepatide with B vitamins. Microdosing is not an FDA-approved dosing plan and research on it is limited, so your provider will talk through what is known before you start.
Is microdosing safer than a standard GLP-1 dose?
Lower doses may mean fewer or milder stomach side effects for some people, but they do not remove the risks of GLP-1 medicines. The boxed warning about thyroid C-cell tumors, and risks like pancreatitis and gallbladder problems, still apply. A licensed provider reviews your history and decides whether a lower-dose plan is appropriate and safe for you.
Which medicines are used in the Microdose program?
There are two options. Microdose Personalized GLP-1 is compounded semaglutide. Microdose Personalized GLP-1/GIP is compounded tirzepatide with added B vitamins. Both are weekly injections compounded by a licensed 503A pharmacy for an individual patient, and neither is FDA-approved. Your provider decides which one, if either, fits your health history and goals.
Can I use a lower dose as a longer-term plan?
Some people and their providers use a lower dose as part of a longer-term metabolic health plan. There is limited research on this approach, and it is not an FDA-approved dosing plan. If you are thinking about stepping down, message the care team so your provider can review your history and decide whether a lower dose or another approach makes sense.
How do I start a microdose plan?
Start the KIN Meds online intake and mention that you are interested in a lower-dose plan. A licensed provider reviews your answers in 24 hours or less and decides whether treatment is appropriate. If it is, your medicine ships from a licensed U.S. partner pharmacy with expedited shipping, cold-packed when needed, with dosing instructions included.
What happens if the provider says treatment is not right for me?
If a licensed provider reviews your intake and decides treatment is not appropriate, you are not charged for treatment. The provider may explain why, suggest a different option in KIN Meds care, or recommend you see a local doctor first. That decision is based on your health history, current medicines and safety, not on which product you picked in the quiz.
A few quick questions, then a licensed provider reviews your intake in 24 hours or less. If treatment is not appropriate, you are not charged for treatment.
General education, not medical advice. Prescription required. A licensed provider decides whether treatment is appropriate for you. Compounded medications are prepared by a licensed 503A pharmacy and are not FDA-approved. Product imagery is illustrative; actual medication form and appearance may differ.